fda glp-1 compounding warning september 2025 issued 25 letters to telehealth companies for false and misleading claims about compounded products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of FDA Targets GLP-1 and Peptide

A recent Washington Post article alludes to Panacea before describing the emerging signs that people living with pain or addiction might benefit from GLP-1s

It closely follows Novo Nordisk's recent playbook: The Emcure Deal: Novo Nordisk previously partnered with Emcure Pharmaceuticals Limited to commercialize Poviztra (a 2.4 mg semaglutide injection), a second brand of their weight-loss drug Wegovy

We would also like to thank Eric Marty for the design of the cannulas used for intrabulbar injections

Maintaining good immune health reduces illnesses and enhances your overall wellness

Thats because 2

Some studies found that people who took GLP-1 medications reported higher levels of anxiety than control groups